← Leaderboards
J Rebecca Liu
University Of Michigan At Ann Arbor
$692,550
Attributed
$692,550
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $138.5K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$692,550 · 1
By mechanism
K08$692,550 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Weiping Zou$38,970,401
- Kathleen R. Cho$7,394,597
- Jacques Eduardo Nor$18,171,241
- Max S. Wicha$49,028,071
- Shaomeng Wang$36,139,079
Others in their field
Top investigators on “Tumor Suppressor Proteins”
- Scott W Lowe · Sloan-Kettering Inst Can Research$30,621,807
- Carol Prives · Icahn School Of Medicine At Mount Sinai$25,974,663
- Pier Paolo Pandolfi · Sloan-Kettering Institute For Cancer Res$25,707,040
- Xinbin Chen · Medical College Of Georgia (Mcg)$23,449,975
- Carlo M Croce · Thomas Jefferson University$21,878,300
- Wei Gu · Columbia University Health Sciences$21,628,257
Research focus
Tumor Suppressor ProteinsApoptosisMalignant NeoplasmsLeadMalignant Neoplasm Of OvaryApoptotic Protease-Activating Factor 1ApoptoticClinically SignificantBaseIn VitroCaspase-9Binding (Molecular Function)Cell LineCell Line, TumorChemotherapyEpithelialCancer Cell LineComplexCareerCytochrome CCaspase-3Functional DisorderEnzyme Induction /RepressionMalignant Epithelial Cell
Grant awards (5)
Role of Phapl in apoptosome regulation in ovarian cancer$138,510
K08 · FY2008 · CA · contact PI
Role of Phapl in apoptosome regulation in ovarian cancer$138,510
K08 · FY2007 · CA · contact PI
Role of Phapl in apoptosome regulation in ovarian cancer$138,510
K08 · FY2006 · CA · contact PI
Role of Phapl in apoptosome regulation in ovarian cancer$138,510
K08 · FY2005 · CA
Role of Phapl in apoptosome regulation in ovarian cancer$138,510
K08 · FY2004 · CA